Earnings Intelligence

Insight-rich articles built from earnings calls.
Stay ahead with how businesses evolve.

High-Value Insights

Articles with exceptional investment signal

20
VERI
Software - Infrastructure

Veritone (VERI) Q4 2025: $12.9M Data Deal Unlocks 50M-Hour Content Pipeline, Pivots to AI Marketplace Scale

Veritone demonstrates a clear long-term reinvestment runway, a disruptive business model, and accelerating growth prospects. The $12.9M data deal, large content pipeline, and...

March 27, 2026
Read full analysis →
17
AAPG
Biotechnology

AAPG Q4 2025: Dual Product Launch Drives 90% Revenue Surge, Global Trial Enrollment Sets 2027 NDA Path

AAPG demonstrates a long reinvestment runway, disruptive dual-product model, and substantial revenue growth. While guidance and backlog are strong, and the business is...

March 26, 2026
Read full analysis →
20
PONY
Information Technology Services

Pony AI (PONY) Q4 2025: RoboTaxi Revenue Set to Triple as Fleet Targets 3,000+ Units

Pony AI demonstrates a long reinvestment runway, hyper-growth trajectory (tripling revenue, 3,000+ fleet target), and improving unit economics. The business model is...

March 26, 2026
Read full analysis →
18
AAPG
Biotechnology

AAPG Q1 2025: Dual-Engine Commercialization Drives 90% Revenue Growth, Global Trial Enrollment Accelerates

AAPG demonstrates a long reinvestment runway, disruptive dual-product model, self-reinforcing commercial and clinical execution, and improving unit economics. Revenue growth is...

March 26, 2026
Read full analysis →
17
MAZE
Biotechnology

Maze Therapeutics (MAZE) Q4 2025: MZE829 Delivers 36% UACR Reduction, Unlocking Broad AMKD Proof-of-Concept

Maze Therapeutics demonstrates a disruptive model with a long runway, high returns, and strong clinical momentum. The business is not yet showing >40% revenue/earnings growth...

March 26, 2026
Read full analysis →
20
CELC
Biotechnology

Selcuity (CELC) Q4 2025: R&D Spend Climbs 40% as Getatilicib Nears $5B Market Opportunity

Selcuity is at a binary inflection with a potentially transformative drug, a large addressable market, and imminent regulatory and data catalysts. The business model is...

March 26, 2026
Read full analysis →
20
PGEN
Biotechnology

PGEN Q4 2025: Pepsimios Launch Drives 149% Revenue Surge, RRP Market Adoption Accelerates

PGEN demonstrates a rare, high-signal commercial inflection: rapid revenue growth, improving unit economics, broadening market opportunity, and strong customer adoption. The...

March 26, 2026
Read full analysis →
20
HIT
Software - Application

HIT Q4 2025: Distribution Network Expands 34%, Unlocking Underpenetrated Self-Funded Health Market

HIT demonstrates a long reinvestment runway, disruptive business model, improving unit economics, and compounding self-reinforcing advantages. The company has posted very...

March 26, 2026
Read full analysis →
View All Insights
EARNINGS INTELLIGENCE

Make Better Investment Decisions

Decode earnings calls with AI-powered analysis.
Spot trends before the market catches on.

About EarningsIQ

EarningsIQ is a strategic reading layer on top of earnings season. We surface company performance, executive priorities, and macro signals, so investors can stay in sync without parsing transcripts.

Join the Smartest Earnings Read in the Market

Subscribe to The Earnings Dispatch
for strategic insights delivered weekly to your inbox.

Free weekly brief. Unsubscribe anytime.

What EarningsIQ Delivers

Actionable Insights

Distilled analysis from earnings calls that cuts through the noise and highlights what truly matters for your investment decisions.

Market Trends

Early identification of emerging sector trends and themes before they become mainstream, giving you an edge in positioning your portfolio.

Time Efficiency

Hours of research condensed into concise, mobile-friendly weekly updates that respect your time while keeping you informed.

Earnings Calendar

Date Company Article
March 20 FUFU Read
March 20 FRAF -
March 20 MIST Read
March 20 ZGN Read
March 20 LAZR Read
March 20 HHS -
March 20 CLLS Read
March 20 WWR Read
March 20 XPEV Read
March 23 ATAI -

Why Earnings Intelligence Matters

In today's fast-moving markets, the signals that drive tomorrow's price movements are often hidden in today's earnings calls.

01

Quarterly earnings calls provide the earliest indicators of business momentum shifts, often weeks before they appear in technical charts.

02

Management commentary offers invaluable forward guidance that helps you anticipate market movements rather than react to them.

03

Our focused analysis helps you separate meaningful signals from market noise, enabling more confident investment decisions.

Stay Strategically Informed

Get The Dispatch , our weekly newsletter
that decodes earnings calls so you can invest with clarity.

Join 10,000+ investors receiving our weekly insights.